PIK3CG and mantle cell lymphoma: However, PI3K inhibitor treatment of MCL cells did not have any significant effect on adhesion of either MCL cell lines (Supplementary Figure 5A) or primary MCL cells to VCAM-1 (n = 2; Supplementary Figure 5B).